İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

EMİNE TERZİ

DOKTOR ÖĞRETİM ÜYESİ

ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 27
  • Proje 0
  • Kitap 3
  • Bildiri 27
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 3 Q2 12 Q3 9 Q4 11
WoS (JCR) Q1 4 Q2 4 Q3 14 Q4 9
TR Index 22 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 3
Ort. yüzdelik 52.0%
Üst %1 payı 0.0%
Üst %10 payı 6.8%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 27 yayın

Scopus (SJR)
Q1 3 Q2 12 Q3 9 Q4 11
WoS (JCR)
Q1 4 Q2 4 Q3 14 Q4 9
TR Index
22 makale

Makale listesi

  1. 2026 Thiazole‐ and 1,3,4‐Thiadiazole‐Based Hybrids: Synthesis and In Vitro Cytotoxicity Against Human Cancer Cell Lines Chemical Biology & Drug Design DOI 10.1111/cbdd.70246 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.0%
  2. 2026 Synthesis, characterization, and anticancer screening of novel thiadiazole derivatives Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.145212 YÖKSİS SJR Q2 JCR Q2 OpenAlex 55.1%
  3. 2026 Exploring Natural Coumarins: Breakthroughs in Anticancer Therapeutics Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/0118715206385367250610045200 YÖKSİS SJR Q3 JCR Q3 OpenAlex 6.8%
  4. 2026 Theobromine as a molecular switch: targeting Nrf2 pathway in invasive and non-invasive bladder cancer Journal of Natural Medicines DOI 10.1007/s11418-025-01961-z YÖKSİS SJR Q2 JCR Q3 OpenAlex 63.5%
  5. 2026 Design, Synthesis, and In Vitro Biological Assessment of Novel Benzimidazole and Hydrazone Derivatives Against Pancreatic Cancer and Melanoma Cells Chemical Biology & Drug Design DOI 10.1111/cbdd.70349 YÖKSİS SJR Q2 JCR Q3 OpenAlex 58.0%
  6. 2026 Selective cytotoxicity of Arctium extracts in pancreatic, bladder, and colorectal cancer cell lines: A comparative dose-response study International Journal of Secondary Metabolite DOI 10.21448/ijsm.1702826 YÖKSİS TR Index SJR Q3 OpenAlex 18.4%
  7. 2026 Comparative Cytotoxic and Anti-Migratory Effects of Cisplatin and Theobromine in Human Bladder Cancer Cells Archives of Current Medical Research DOI 10.47482/acmr.1888215 YÖKSİS TR Index OpenAlex 50.7%
  8. 2026 Assessment of theobromine-induced cytotoxicity in bladder cancer cell lines: Determination of IC50 values step-by-step using RStudio Turkish Bulletin of Hygiene and Experimental Biology DOI 10.5505/TurkHijyen.2026.65031 YÖKSİS TR Index SJR Q4 OpenAlex 30.8%
  9. 2026 The Effects of Carbonic Anhydrase IX Inhibition with AAZ on mTOR Signaling Pathway in Renal Carcinoma Cells Bratislava Medical Journal DOI 10.1007/s44411-026-00527-z YÖKSİS SJR Q3 JCR Q2 OpenAlex 12.0%
  10. 2026 Theobromine suppresses NF-κB signaling and promotes apoptosis in lung cancer and osteosarcoma cells International Journal of Medical Biochemistry DOI 10.14744/ijmb.2026.30592 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex üst %10 OpenAlex 93.3%
  11. 2025 β-Arbutin and cisplatin: A combined approach to modulating apoptosis, cell viability, and migration in bladder cancer cells Toxicology in Vitro DOI 10.1016/j.tiv.2024.105985 YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.2%
  12. 2025 Targeting Ras Signaling via Carbonic Anhydrase IX Inhibition: Differential Impact of Acetazolamide on Clear Cell Renal Carcinoma and Melanoma Cells Experimed DOI 10.26650/experimed.1703562 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 20.3%
  13. 2025 Comparison of the effects of β-Arbutin on the NF-κB pathway in two-dimensional (2D) and three-dimensional (3D) colorectal cancer cell lines Chemico-Biological Interactions DOI 10.1016/j.cbi.2025.111533 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.6%
  14. 2025 Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Benzothiazole-Based 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/0118715206353584241018051852 YÖKSİS SJR Q3 JCR Q3 OpenAlex 83.2%
  15. 2024 Effect of herniarin on cell viability, cell cycle, and Erk protein levels in different stages of bladder cancer cells Chemistry & Biodiversity DOI 10.1002/cbdv.202301645 YÖKSİS SJR Q3 JCR Q3 OpenAlex 83.4%
  16. 2024 Design, Synthesis, and Biological Evaluation of New Benzimidazole‐1,2,4‐Triazole Derivatives as Potential Anticancer Agents Chemical Biology & Drug Design DOI 10.1111/cbdd.70033 YÖKSİS SJR Q2 JCR Q2 OpenAlex 70.6%
  17. 2024 A Clinical Sulfonamide Derivative Inhibits B-Raf Protein in Colorectal Cancer and Melanoma Cells. Is It a New Target for Cancer? Experimed DOI 10.26650/experimed.1378000 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 2.3%
  18. 2023 Investigation of Protein Expressions of PLA2G7, UCP2 and NEDD4L Genes Associated with Fat Droplet Formation in Prostate Cancer Online Turkish Journal of Health Sciences DOI 10.26453/otjhs.1330334 YÖKSİS TR Index OpenAlex 47.6%
  19. 2023 Kolorektal Kanserde Rapamisin ve Vemurafenib’in Apoptotik Etkilerinin Karşılaştırılması Uludağ Üniversitesi Tıp Fakültesi Dergisi DOI 10.32708/uutfd.1376556 YÖKSİS TR Index OpenAlex 47.8%
  20. 2022 Karbonik Anhidraz-IX Enziminin Asetazolamid ile İnhibisyonunun Glutatyon Redüktaz ve Glutatyon Peroksidaz Aktiviteleri Üzerine Olan Etkisinin İncelenmesi Uludağ Üniversitesi Tıp Fakültesi Dergisi DOI 10.32708/uutfd.1124693 YÖKSİS TR Index OpenAlex 37.5%

Akademisyenlere dön